DIAGNOSIS AND TREATMENT OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
https://doi.org/10.14412/1995-4484-2018-500-505
Abstract
The review analyzes the foreign and Russian literature published in the past 30 years and devoted to the diagnosis and treatment of coxitis in ankylosing spondylitis (AS). The results of previous works have revealed the high rate of hip joint injury (HJI) in AS, but it is still unclear which diagnostic technique is the most sensitive for the early detection of coxitis. The latter has been shown to serve as one of the predictors of early disability in patients. The most studied treatment for coxitis is now HJI endoprosthesis, for which indications and contraindications have been clearly developed, while the question of drug therapy remains open.
About the Authors
E. M. Agafonova
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
T. V. Dubinina
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
Sh. F. Erdes
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
References
1. Erdes ShF, Bochkova AG, Dubinina TV, et al. Project of working classification of ankylosing spondilytis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(6):604-8 (In Russ.)]. doi: 10.14412/1995-4484-2013-604-8
2. Folomeeva OM, Galushko EA, Erdes ShF. Prevalence of rheumatic diseases in adult populations of Russian Federation and USA. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2008;46(4):4-13 (In Russ.)]. doi: 10.14412/1995-4484-2008-529
3. Benevolenskaya LI, Boyer GS, Erdesz Sh, et al.Spondylarthropathic diseases in indigenous circumpolar populations of Russia and Alaska. Rev Rhum Engl Ed. 1996 Dec;63(11):815-22.
4. Chorus AM, Miedema HS, Boonen A, et al. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis. 2003;62:1178-84. doi: 10.1136/ard.2002.004861
5. Zochling J, Braun J. Mortality in ankylosing spondylitis. Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S80-4. Review.
6. Rkain H, Allali F, Bentalha A, et al. Socioeconomic impact of ankylosing spondylitis in Morocco. Clin Rheumatol. 2007 Dec;26(12):2081-8. Epub 2007 Apr 25. doi: 10.1007/s10067-007-0622-1
7. Rafia R, Ara R, Packham J, et al. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):246-53. Epub 2012 Apr 13.
8. Boonen A, van der Heijde D, Landewe R, et al. Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis. 2003;62:732-40. doi: 10.1136/ard.62.8.732
9. Verstappen SMM, Boonen A, Jacobs JWG, et al. The burden of illness: ankylosing spondylitis vs rheumatoid arthritis. Ann Rheum Dis. 2006;65(Suppl II):605.
10. Boonen A, van der Linden SM. The burden of ankylosing spondylitis. J Rheumatol Suppl. 2006 Sep;78:4-11.
11. Brunner R, Kissling RO, Auckenthaler C, et al. Clinical Evaluation of Ankylosing Spondylitis in Switzerland. Pain Physician. 2002 Jan;5(1):49-56.
12. Gran JT, Scomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol. 1997;36:766-71. doi: 10.1093/rheumatology/36.7.766
13. Boonen A, Cruyssen BV, de Vlam K, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009;36:1249-55. doi: 10.3899/jrheum.0808312
14. Amor B, Santos RS, Nahal R, et al. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol. 1994;21:1883-7.
15. Podryadnova MV, Balabanova RM, Urumova MM, Erdes ShF. Coxitis in ankylosing spondylitis: Comparison of clinical manifestations with ultrasound study data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):417-22 (In Russ.)]. doi: 10.14412/1995-4484-2014-417-422
16. Bochkova AG. Modern approaches to early diagnosis of ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2009;47(5):24-9 (In Russ.)]. doi: 10.14412/1995-4484-2009-585
17. Baraliakos X, Braun J. Hip involvement in ankylosing spondylitis. What is the verdict? Rheumatology. 2010;49:3-4. doi: 10.1093/rheumatology/kep298
18. Vander Cruyssen B, Munoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology. 2010;49(1):73-81. doi: 10.1093/rheumatology/kep174
19. Volnukhin EV, Galushko EA, Bochkova AG, et al. Clinical diversity of ankylosing spondylitis in the real practice of a rheumatologist in Russia (Part1). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;50(2):44-9 (In Russ.)].
20. doi: 10.14412/1995-4484-2012-1272
21. Bochkova AG, Rumyantseva OA, Severinova MV, et al. Coxitis in patients with ankylosing spondyli-tis: clinicoradio logic comparisons. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2005;43(4):8-13 (In Russ.)]. doi: 10.14412/1995-4484-2005-610
22. Marks JS, Hardinge K. Clinical and radiographic features of spondylitis hip disease. Ann Rheum Dis. 1979;38:332-6. doi: 10.1136/ard.38.4.332
23. Dwosh IL, Resnick D, Becker MA. Hip involvement in ankylosing spondylitis. Arthritis Rheum. 1976;19:683-92.
24. doi: 10.1002/1529-0131(197607/08)19:43.0.CO;2-8
25. Kalin A, Elswood J. The outcome of 138 total hip replacement and 12 revisions in ankylosing spondylitis: high success rate after a mean followup of 7.5 years. J Rheumatol. 1989;16:955-8.
26. Falkenbach A, Franke A, van der Linden S. Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol. 2003;30(10):2186-92.
27. Brophy PJ. Axoglia junctions: separate the channels or scramble the message. Curr Biol. 2001;11(14):R555-7. doi: 10.1016/S0960-9822(01)00341-4
28. Van der Cruyssen В, Vastesaeger N, Collantes-Estevez E. Hip disease in ankylosing spondylitis. Curr Opin Rheumatol. 2013;25:448-54. doi: 10.1097/BOR.0b013e3283620e04
29. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology. 2006;45:129-38. doi:10.1093/rheumatology/kei171
30. Resnick D, Nimwayama G. Diagnosis of bone and join disorders.
31. W. B. Saunders Company; 1981. Vol. 2. P. 1074-80.
32. Ilyushina LV, Il'inykh EI, Mazurov VI. Hip involvement in ankylosing spondylitis. Doktor.Ru. 2013;6(84):42-5 (In Russ.)].
33. Bochkova AG, Levshakova AV, Tyukhova EYu, et al. Magnetic-resonance imaging for early diagnosis of coxitis in patients with spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;50(5):56-63 (In Russ.)]. doi: 10.14412/1995-4484-2012-1183
34. Boersma JW. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scand J Rheumatol. 1976;5:60-4.
35. Wanders A, van der Heijde D, Landewe R, et al. Non-steroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756-65. doi: 10.1002/art.21054
36. Nasonov EL. 50 years of methotrexate in rheumatology. Russkii Meditsinskii Zhurnal. 2000;(9):372-6 (In Russ.)].
37. Chen J, Lui C. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev. 2004;3:CD004524.
38. Haibel H, Brandt HC, Song IH, et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis. 2007;66:419-21.
39. doi: 10.1136/ard.2006.054098
40. Dubinina TV, Demina AB, Erdes ShF. Methotrexate in the treatment of coxitis in early spondyloarthritis: Are there prospects? Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(4):452-5 (In Russ.)]. doi: 10.14412/1995-4484-2015-452-455
41. Rumyantseva OA, Bochkova AG, Loginova EYu, et al. Intravenous application of high doses of glucocorticoids in patients with ankylosing spondylitis.Terapevticheskiy Arkhiv. 2006;(12):71-5 (In Russ.)].
42. Bochkova AG. Seronegative spondylitis. Treatment of ankylosing spondylitis. Zhurnal Dokazatel'noy Meditsiny Dlya Praktikuyushchikh Vrachey. 2006;8:2 (In Russ.)].
43. Mackay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI). A new validated approach to disease assessment. Arthritis Rheum. 1998;41:2263-70. doi:10.1002/1529-0131(199812)41:123.0.CO;2-I
44. Richter MB, Woo P, Panayi GS, et al. The effects of intravenous pulse methylpredniso-lone on immunological and inflammatory procecesses in ankylosing spondylitis. Clin Exp Immunol. 1983;53:51-9.
45. Rumyantseva OA, Bochkova AG, Loginova EYu, et al. Investigation of efficacy, safety and tolerability of inflix-simab in patients with ankylosing spondylitis. Effektivnaya Farmakoterapiya. 2011;39:32-7 (In Russ.)
46. Konsta M, Sfikakis PP, Bournia VK. Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol. 2013;32(8):1229-32.
47. doi: 10.1007/s10067-013-2263-x
48. Nystad TW, Fevang BS, Havelin LI, et al. THU0362 Hip Replacement Surgery in Patients with Ankylosing Spondylitis. Ann Rheum Dis. 2013;72:A288.
Review
For citations:
Agafonova E.M., Dubinina T.V., Erdes Sh.F. DIAGNOSIS AND TREATMENT OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS. Rheumatology Science and Practice. 2018;56(4):500-505. (In Russ.) https://doi.org/10.14412/1995-4484-2018-500-505
Views:
6764
Email this article 